AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31556580 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro fertilization (IVF)
Number of subjects: 158
Study 31556580 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous conception (SC)
Number of subjects: 158
Study 30974395 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic Gait Training (RGT) program three times a week for 12 weeks
Number of subjects: 24
Study 30974395 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy rehabilitation (PTR) program three days a week for 12 weeks
Number of subjects: 24
Study 28380213 — intervention group
Group type: EXPERIMENTAL
Intervention: MCAO+RA group
Number of subjects: 216
Study 28380213 — intervention group
Group type: COMPARATOR
Intervention: MCAO+vehicle group
Number of subjects: 216
Study 28380213 — intervention group
Group type: COMPARATOR
Intervention: sham‐operated group
Number of subjects: 216
Study 27215809 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate (MTA)
Number of subjects: 260
Study 27215809 — intervention group
Group type: COMPARATOR
Intervention: Super Ethoxybenzoic Acid (Super EBA)
Number of subjects: 260
Study 27215809 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall success rate
Number of subjects: 260
Study 27215809 — intervention group
Group type: COMPARATOR
Intervention: Comparison of MTA and Super EBA
Number of subjects: 260
Study 27215809 — intervention group
Group type: COMPARATOR
Intervention: Comparison of follow-up periods
Number of subjects: 260
Study 25052724 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone 25 mg/d
Number of subjects: 82
Study 25052724 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 21940392 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphatic staining method
Number of subjects: 62
Study 21940392 — intervention group
Group type: COMPARATOR
Intervention: Control unstained group
Number of subjects: 62
Study 19421321 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (0.5 g/kg/d)
Number of subjects: 30
Study 19421321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 17205318 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine lozenges
Number of subjects: 145
Study 17205318 — intervention group
Group type: COMPARATOR
Intervention: Placebo lozenges
Number of subjects: 145
Study 15068500 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 or 120 mg/day)
Number of subjects: 0
Study 15068500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15675639 — intervention group
Group type: EXPERIMENTAL
Intervention: Word context benefit at the fovea
Number of subjects: 0
Study 15675639 — intervention group
Group type: EXPERIMENTAL
Intervention: Word context benefit at the periphery
Number of subjects: 0
Study 15675639 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated interletter spacing
Number of subjects: 0
Study 11889743 — intervention group
Group type: EXPERIMENTAL
Intervention: Study mattress (advanced, non-powered, air and foam surface)
Number of subjects: 20
Study 11889743 — intervention group
Group type: COMPARATOR
Intervention: Low-air-loss mattress
Number of subjects: 20
Study 9781971 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 1153
Study 9781971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1153
Study 7949022 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy
Number of subjects: 8
Study 3064191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined modality treatment (radiotherapy and chemotherapy)
Number of subjects: 227
Study 3064191 — intervention group
Group type: COMPARATOR
Intervention: No adjuvant therapy
Number of subjects: 227
Study 3064191 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy only
Number of subjects: 227
Study 3064191 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy only
Number of subjects: 227
Study 29658764 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 177
Study 29658764 — intervention group
Group type: COMPARATOR
Intervention: Mediation as Usual (MAU)
Number of subjects: 177
Study 28094135 — intervention group
Group type: EXPERIMENTAL
Intervention: VA‐DPP
Number of subjects: 387
Study 28094135 — intervention group
Group type: COMPARATOR
Intervention: MOVE!
Number of subjects: 387
Study 26674253 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark chocolate (DC) 40 g daily
Number of subjects: 9
Study 26674253 — intervention group
Group type: COMPARATOR
Intervention: White chocolate (WC)
Number of subjects: 9
Study 26674253 — intervention group
Group type: COMPARATOR
Intervention: Baseline (BL)
Number of subjects: 9
Study 24092978 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine 18 mg patch with domperidone 30 mg (RWD)
Number of subjects: 30
Study 24092978 — intervention group
Group type: COMPARATOR
Intervention: Rivastigmine 18 mg patch without domperidone (RWOD)
Number of subjects: 30
Study 21466595 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate (RIS) 35 mg/week plus calcium 1000 mg/day and vitamin D(3) 800 IU/day
Number of subjects: 89
Study 21466595 — intervention group
Group type: COMPARATOR
Intervention: Calcium 1000 mg/day and vitamin D(3) 800 IU/day
Number of subjects: 89
Study 21466595 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 89
Study 18809520 — intervention group
Group type: EXPERIMENTAL
Intervention: Entropy-guided anesthesia
Number of subjects: 65
Study 18809520 — intervention group
Group type: COMPARATOR
Intervention: Conventional anesthesia
Number of subjects: 65
Study 16410062 — intervention group
Group type: EXPERIMENTAL
Intervention: Ledermix
Number of subjects: 88
Study 16410062 — intervention group
Group type: EXPERIMENTAL
Intervention: Septomixine
Number of subjects: 88
Study 16410062 — intervention group
Group type: EXPERIMENTAL
Intervention: Calasept
Number of subjects: 88
Study 12627187 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased folate intake through diet and supplement (400 microg folic acid)
Number of subjects: 126
Study 10853164 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural corticosteroid injection (100 mg methylprednisolone in 10 mL bupivacaine 0.25%)
Number of subjects: 36
Study 10853164 — intervention group
Group type: COMPARATOR
Intervention: Control group (no epidural corticosteroid injection)
Number of subjects: 36
Study 10853164 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural corticosteroid injection
Number of subjects: 36
Study 8966823 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal exposure to phenobarbital
Number of subjects: 114
Study 8966823 — intervention group
Group type: COMPARATOR
Intervention: Control group (unexposed men)
Number of subjects: 114
Study 1556404 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,200 mg Mg(OH)2
Number of subjects: 6
Study 1556404 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,400 mg Mg(OH)2
Number of subjects: 6
Study 1556404 — intervention group
Group type: EXPERIMENTAL
Intervention: 3,600 mg Mg(OH)2
Number of subjects: 6
Study 1556404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 1556404 — intervention group
Group type: EXPERIMENTAL
Intervention: Mg(OH)2 (all doses)
Number of subjects: 6
Study 3890497 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 60
Study 3890497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30321900 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical Massage Therapy (KMT)
Number of subjects: 132
Study 30321900 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture Therapy (AKU)
Number of subjects: 132
Study 30379867 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor housing with protection from heat stress
Number of subjects: 581
Study 30379867 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasture access with heat stress
Number of subjects: 581
Study 30379867 — intervention group
Group type: COMPARATOR
Intervention: Indoor housing with heat stress
Number of subjects: 581
Study 30379867 — intervention group
Group type: EXPERIMENTAL
Intervention: Pasture access with protection from heat stress
Number of subjects: 581
Study 27179722 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 6000
Study 27179722 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 6000
Study 25098587 — intervention group
Group type: EXPERIMENTAL
Intervention: Insert (two-page, evidence-based article)
Number of subjects: 179833
Study 25098587 — intervention group
Group type: EXPERIMENTAL
Intervention: Outsert (short, directive message stapled to the newsletter)
Number of subjects: 179833
Study 25098587 — intervention group
Group type: EXPERIMENTAL
Intervention: Both insert and outsert
Number of subjects: 179833
Study 25098587 — intervention group
Group type: EXPERIMENTAL
Intervention: Both insert, outsert, and patient reminder
Number of subjects: 179833
Study 25098587 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 179833
Study 23151294 — intervention group
Group type: EXPERIMENTAL
Intervention: Turned implants (Tur)
Number of subjects: 14
Study 23151294 — intervention group
Group type: COMPARATOR
Intervention: Moderately rough implants (TiUnite, TiU)
Number of subjects: 14
Study 19465191 — intervention group
Group type: EXPERIMENTAL
Intervention: Emulsified fish oil
Number of subjects: 10
Study 19465191 — intervention group
Group type: COMPARATOR
Intervention: Capsular triglyceride fish oil
Number of subjects: 10
Study 17469883 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive-behavioral therapy (CBT) plus care management
Number of subjects: 393
Study 15281999 — intervention group
Group type: EXPERIMENTAL
Intervention: Coasted group
Number of subjects: 78
Study 15281999 — intervention group
Group type: COMPARATOR
Intervention: Non-coasted group
Number of subjects: 78
Study 12215984 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 2.0 mg/mL
Number of subjects: 30
Study 12215984 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 5.0 mg/mL
Number of subjects: 30
Study 12215984 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 7.5 mg/mL
Number of subjects: 30
Study 10412335 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental controls (wrapping mattress with vinyl cover, washing bedding with hot water every two weeks, removal of soft furniture, wet cleaning bedroom floor daily)
Number of subjects: 30
Study 10412335 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study 7734555 — intervention group
Group type: EXPERIMENTAL
Intervention: Curled catheter
Number of subjects: 72
Study 7734555 — intervention group
Group type: COMPARATOR
Intervention: Straight catheter
Number of subjects: 72
Study 1706024 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary protein intake
Number of subjects: 96
Study 1706024 — intervention group
Group type: EXPERIMENTAL
Intervention: Animal protein intake
Number of subjects: 96
Study 1706024 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary sodium intake
Number of subjects: 96
Study 1706024 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary potassium intake
Number of subjects: 96
Study 6264292 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 20
Study 6264292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6464626 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative treatment with nasogastric tubes
Number of subjects: 97
Study 6464626 — intervention group
Group type: COMPARATOR
Intervention: Postoperative treatment without nasogastric tubes
Number of subjects: 97
Study 30206369 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin (SP arm)
Number of subjects: 108
Study 30206369 — intervention group
Group type: COMPARATOR
Intervention: vinorelbine plus cisplatin (VP arm)
Number of subjects: 108
Study 26745715 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Therapy (CBT) intervention for weight loss
Number of subjects: 119
Study 24948508 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogel coils
Number of subjects: 447
Study 24948508 — intervention group
Group type: COMPARATOR
Intervention: Platinum coils
Number of subjects: 447
Study 23054164 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater concern about exposure to occupational hazards
Number of subjects: 0
Study 23054164 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive view of their unions
Number of subjects: 0
Study 23054164 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age, higher levels of educational attainment and household income, fewer cigarettes smoked per day
Number of subjects: 0
Study 20336537 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LO)
Number of subjects: 50
Study 20336537 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (CO)
Number of subjects: 50
Study 20336537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 19024521 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg twice daily for 7 days
Number of subjects: 59
Study 19024521 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 59
Study 19024521 — intervention group
Group type: COMPARATOR
Intervention: Control (surgical resection alone)
Number of subjects: 59
Study 16244520 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular electrical stimulation
Number of subjects: 61
Study 16244520 — intervention group
Group type: COMPARATOR
Intervention: Cuff-type sling (Control)
Number of subjects: 61
Study 11124750 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole (administered every 2 months for 8 months and again at 12 months)
Number of subjects: 123
Study 11124750 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets (administered every 2 months for 8 months and again at 12 months)
Number of subjects: 123
Study 11124750 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 123
Study 9272808 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with a history of injection drug use (IDU)
Number of subjects: 516
Study 9272808 — intervention group
Group type: COMPARATOR
Intervention: Patients without a history of injection drug use (non-IDU)
Number of subjects: 516
Study 9272808 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients acknowledging continued drug use
Number of subjects: 516
Study 9272808 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients denying any recent drug use
Number of subjects: 516
Study 9272808 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients participating in a methadone maintenance program
Number of subjects: 516
Study 7878558 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 mg terbutaline from a pressurised metered dose inhaler (MDI) with spacer (4 x 0.25 mg doses)
Number of subjects: 15
Study 7878558 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg terbutaline from a Turbohaler (2 x 0.5 mg doses)
Number of subjects: 15
Study 7878558 — intervention group
Group type: COMPARATOR
Intervention: Placebo from a pressurised metered dose inhaler (MDI)
Number of subjects: 15
Study 7878558 — intervention group
Group type: COMPARATOR
Intervention: Placebo from a Turbohaler
Number of subjects: 15
Study 2975458 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (2 pmol/kg/minute for two hours) in sodium-replete normal subjects
Number of subjects: 200
Study 2975458 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental doses of synthetic atrial natriuretic peptide in sodium-replete dogs
Number of subjects: 200
Study 2975458 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental doses of synthetic atrial natriuretic peptide in sodium-depleted dogs
Number of subjects: 200
Study 2975458 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (10 pmol/kg/minute for one hour) in patients with end-stage renal failure
Number of subjects: 200
Study 2975458 — intervention group
Group type: COMPARATOR
Intervention: Placebo in sodium-replete normal subjects
Number of subjects: 200
Study 2975458 — intervention group
Group type: COMPARATOR
Intervention: Placebo in sodium-replete dogs
Number of subjects: 200
Study 2975458 — intervention group
Group type: COMPARATOR
Intervention: Placebo in sodium-depleted dogs
Number of subjects: 200
Study 30403576 — intervention group
Group type: EXPERIMENTAL
Intervention: CGM+CSII
Number of subjects: 75
Study 30403576 — intervention group
Group type: COMPARATOR
Intervention: CGM+MDI (control)
Number of subjects: 75
Study 27418254 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization
Number of subjects: 0
Study 24535888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexinidazole single dose (100 to 3,600 mg)
Number of subjects: 154
Study 24535888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexinidazole multiple ascending doses (up to 3,600 mg/day for 14 days)
Number of subjects: 154
Study 24535888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexinidazole loading dose of 1,800 mg/day for 4 days followed by 1,200 mg/day for 6 days with a normal meal
Number of subjects: 154
Study 24535888 — intervention group
Group type: COMPARATOR
Intervention: Fexinidazole tablet formulation
Number of subjects: 154
Study 24535888 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexinidazole with food intake
Number of subjects: 154
Study 24535888 — intervention group
Group type: COMPARATOR
Intervention: Fexinidazole with low-fat regimen
Number of subjects: 154
Study 22872689 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight glucose control (TGC)
Number of subjects: 700
Study 22872689 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 700
Study 20679638 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (target dosage = 80 mg/day)
Number of subjects: 55
Study 20679638 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 17287629 — intervention group
Group type: EXPERIMENTAL
Intervention: Early compression stockings (immediately after diagnosis)
Number of subjects: 73
Study 17287629 — intervention group
Group type: COMPARATOR
Intervention: Control group (compression stockings started 2 weeks after diagnosis)
Number of subjects: 73
Study 16095471 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioural Therapy (CBT)
Number of subjects: 88
Study 16095471 — intervention group
Group type: COMPARATOR
Intervention: Group Psychoeducation (PE)
Number of subjects: 88
Study 12229974 — intervention group
Group type: EXPERIMENTAL
Intervention: 900 mg/day UDCA
Number of subjects: 15
Study 9523249 — intervention group
Group type: EXPERIMENTAL
Intervention: styrene exposure
Number of subjects: 25
Study 7661476 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia and postoperative patient-controlled intravenous narcotic analgesia (GEN)
Number of subjects: 78
Study 7661476 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia and postoperative continuous epidural analgesia (EPI)
Number of subjects: 78
Study 7661476 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia (GEN)
Number of subjects: 78
Study 7661476 — intervention group
Group type: COMPARATOR
Intervention: Epidural anesthesia (EPI)
Number of subjects: 78
Study 2547680 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril, 0.5 mg.kg‐1.day‐1 for 4 weeks
Number of subjects: 18
Study 2547680 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 18
Study 1095108 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial infusion of Solcoseryl
Number of subjects: 57
Study 30599063 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 117
Study 30599063 — intervention group
Group type: COMPARATOR
Intervention: Dabigatran
Number of subjects: 117
Study 30599063 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 117
Study 29361939 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin-based combination therapy
Number of subjects: 264
Study 29361939 — intervention group
Group type: EXPERIMENTAL
Intervention: Chloroquine with primaquine (7-9 days: total dose 3-4.2 mg/kg)
Number of subjects: 264
Study 29361939 — intervention group
Group type: EXPERIMENTAL
Intervention: Another artemisinin-based combination therapy
Number of subjects: 264
Study 26184830 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorion membrane placement at test sites during periodontal flap surgery
Number of subjects: 0
Study 26184830 — intervention group
Group type: COMPARATOR
Intervention: Control sites (no chorion membrane) during periodontal flap surgery
Number of subjects: 0
Study 24877997 — intervention group
Group type: EXPERIMENTAL
Intervention: Celgosivir (initial 400 mg loading dose within 6 h of randomisation, followed by 200 mg every 12 h for a total of nine doses)
Number of subjects: 50
Study 24877997 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 24877997 — intervention group
Group type: EXPERIMENTAL
Intervention: Celgosivir
Number of subjects: 50
Study 22270489 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-leg passive cycling at 60 RPM
Number of subjects: 11
Study 22270489 — intervention group
Group type: COMPARATOR
Intervention: One-leg passive cycling at 60 RPM
Number of subjects: 11
Study 22270489 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-leg passive cycling at 90 RPM
Number of subjects: 11
Study 22270489 — intervention group
Group type: COMPARATOR
Intervention: One-leg passive cycling at 90 RPM
Number of subjects: 11
Study 22270489 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated trials of passive cycling
Number of subjects: 11
Study 19508318 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based programme consisting of 40 weekly visits
Number of subjects: 59
Study 19508318 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional home-based programme)
Number of subjects: 59
Study 17489029 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 15130862 — intervention group
Group type: EXPERIMENTAL
Intervention: University-based (UB) group
Number of subjects: 40
Study 15130862 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based (HB) group
Number of subjects: 40
Study 11906418 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative bupivacaine infiltration
Number of subjects: 18
Study 11906418 — intervention group
Group type: COMPARATOR
Intervention: Control (non-infiltrated groin)
Number of subjects: 18